Common Stock
- Symbol
- VTAK
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Historical · closed Oct 2, 2026
Current Report · Items 9.01 · 8-K/A
Flyte Aviation, Inc.
Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. (a) Financial Statements of Businesses Acquired. The audited combined financial statements of FLYTE as of and for the years ended December 31, 2025 and December 31, 2024, and the related notes thereto, together with the report of WithumSmith+Brown, PC, independent registered public accounting firm, are filed as Exhibit 99.1 to this Amendme…
Company context
Current securities
Historical securities (1)
Recent company filings
- Regulation FD DisclosureOct 14, 2026
- Results of Operations and Financial ConditionOct 13, 2026
- Unregistered Sales of Equity Securities · Other EventsOct 9, 2026
- Regulation FD Disclosure · Other EventsOct 5, 2026
- Material Modification to Rights of Security Holders · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders · Other EventsOct 2, 2026
Registered securities in this filing
Catheter Precision, Inc. · 8-K/A · Filed 2026-07-29
Disclosure sections
Item 9.01Item 9.01 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
(a) Financial Statements of Businesses Acquired.
The audited combined financial statements of FLYTE as of and for the years ended December 31, 2025 and December 31, 2024, and the related notes thereto, together with the report of WithumSmith+Brown, PC, independent registered public accounting firm, are filed as Exhibit 99.1 to this Amendment and are incorporated herein by reference.
(b) Pro Forma Financial Information.
The unaudited pro forma condensed combined financial statements of the Company giving effect to the Acquisition, consisting of an unaudited pro forma condensed combined statement of operations for the year ended December 31, 2025, and the related notes thereto, is filed as Exhibit 99.2 to this Amendment and is incorporated herein by reference.
Exhibit No. Description
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
23.1 Consent of WithumSmith+Brown, PC, independent registered public accounting firm.
99.1 Audited combined financial statements of FLYTE as of and for the years ended December 31, 2025 and December 31, 2024.
99.2 Unaudited pro forma condensed combined financial statements of Catheter Precision, Inc. for the year ended December 31, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).